17-Dec-2025
J.P. Morgan Remains a Buy on Thermo Fisher (TMO)
TipRanks (Tue, 16-Dec 6:46 AM ET)
Business Wire (Mon, 15-Dec 10:11 AM ET)
Bank of America Securities Sticks to Their Buy Rating for Thermo Fisher (TMO)
TipRanks (Mon, 15-Dec 7:25 AM ET)
Analysts’ Top Healthcare Picks: Novan (NOVN), Thermo Fisher (TMO)
TipRanks (Mon, 15-Dec 6:41 AM ET)
Business Wire (Tue, 2-Dec 5:00 PM ET)
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
Business Wire (Mon, 24-Nov 9:10 PM ET)
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
Business Wire (Thu, 20-Nov 4:15 PM ET)
Business Wire (Wed, 12-Nov 8:00 AM ET)
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
Business Wire (Thu, 6-Nov 4:35 PM ET)
Thermo Fisher Scientific Declares Quarterly Dividend
Business Wire (Thu, 6-Nov 4:30 PM ET)
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Thermo Fisher Scientific trades on the NYSE stock market under the symbol TMO.
As of December 17, 2025, TMO stock price declined to $562.56 with 1,466,180 million shares trading.
TMO has a beta of 0.80, meaning it tends to be less sensitive to market movements. TMO has a correlation of 0.19 to the broad based SPY ETF.
TMO has a market cap of $212.23 billion. This is considered a Mega Cap stock.
Last quarter Thermo Fisher Scientific reported $11 billion in Revenue and $5.79 earnings per share. This beat revenue expectation by $209 million and exceeded earnings estimates by $.29.
In the last 3 years, TMO traded as high as $627.88 and as low as $385.46.
The top ETF exchange traded funds that TMO belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
TMO has underperformed the market in the last year with a price return of +6.7% while the SPY ETF gained +12.3%. However, in the short term, TMO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +19.1% vs +2.1% return in SPY. But in the last 2 weeks, TMO shares have been beat by the market, returning -3.0% compared to an SPY return of -1.8%.
TMO support price is $562.06 and resistance is $578.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMO shares will trade within this expected range on the day.